These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31942853)

  • 1. Neuroprotective and Neurorestorative Effects of Epo and VEGF: Perspectives for New Therapeutic Approaches to Neurological Diseases.
    Ureña-Guerrero ME; Castañeda-Cabral JL; Rivera-Cervantes MC; Macias-Velez RJ; Jarero-Basulto JJ; Gudiño-Cabrera G; Beas-Zárate C
    Curr Pharm Des; 2020; 26(12):1263-1276. PubMed ID: 31942853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The erythropoietin-derived peptide MK-X and erythropoietin have neuroprotective effects against ischemic brain damage.
    Yoo SJ; Cho B; Lee D; Son G; Lee YB; Soo Han H; Kim E; Moon C; Moon C
    Cell Death Dis; 2017 Aug; 8(8):e3003. PubMed ID: 28817120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury.
    Taoufik E; Petit E; Divoux D; Tseveleki V; Mengozzi M; Roberts ML; Valable S; Ghezzi P; Quackenbush J; Brines M; Cerami A; Probert L
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6185-90. PubMed ID: 18413601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Erythropoietin and vascular endothelial growth factor level in normoxia and in cerebral ischemia under pharmacological and hypoxic preconditioning].
    Novikov VE; Levchenkova OS
    Biomed Khim; 2020 Jul; 66(4):339-344. PubMed ID: 32893824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
    Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability.
    Martínez-Estrada OM; Rodríguez-Millán E; González-De Vicente E; Reina M; Vilaró S; Fabre M
    Eur J Neurosci; 2003 Nov; 18(9):2538-44. PubMed ID: 14622154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin and the hypoxic brain.
    Marti HH
    J Exp Biol; 2004 Aug; 207(Pt 18):3233-42. PubMed ID: 15299044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
    Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
    Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin but not VEGF has a protective effect on auditory hair cells in the inner ear.
    Monge Naldi A; Gassmann M; Bodmer D
    Cell Mol Life Sci; 2009 Nov; 66(22):3595-9. PubMed ID: 19763398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal neuro EPO could be a reliable choice for neuroprotective stroke treatment.
    Parra AL; Rodriguez JC
    Cent Nerv Syst Agents Med Chem; 2012 Mar; 12(1):60-8. PubMed ID: 22376076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats.
    Böcker-Meffert S; Rosenstiel P; Röhl C; Warneke N; Held-Feindt J; Sievers J; Lucius R
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):2021-6. PubMed ID: 12037014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures.
    Yoo JY; Won YJ; Lee JH; Kim JU; Sung IY; Hwang SJ; Kim MJ; Hong HN
    J Neurosci Res; 2009 Jan; 87(1):150-63. PubMed ID: 18711747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of HIF in cobalt-induced ischemic tolerance.
    Jones SM; Novak AE; Elliott JP
    Neuroscience; 2013 Nov; 252():420-30. PubMed ID: 23916558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
    J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin attenuates renal and pulmonary injury in polymicrobial induced-sepsis through EPO-R, VEGF and VEGF-R2 modulation.
    Heitrich M; García DM; Stoyanoff TR; Rodríguez JP; Todaro JS; Aguirre MV
    Biomed Pharmacother; 2016 Aug; 82():606-13. PubMed ID: 27470403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
    Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
    Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NeuroEPO Preserves Neurons from Glutamate-Induced Excitotoxicity.
    Garzón F; Coimbra D; Parcerisas A; Rodriguez Y; García JC; Soriano E; Rama R
    J Alzheimers Dis; 2018; 65(4):1469-1483. PubMed ID: 30175978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.
    Montero M; Poulsen FR; Noraberg J; Kirkeby A; van Beek J; Leist M; Zimmer J
    Exp Neurol; 2007 Mar; 204(1):106-17. PubMed ID: 17157835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective action of erythropoietin on neuronal damage induced by activated microglia.
    Wenker SD; Chamorro ME; Vittori DC; Nesse AB
    FEBS J; 2013 Apr; 280(7):1630-42. PubMed ID: 23384249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells.
    Weishaupt JH; Rohde G; Pölking E; Siren AL; Ehrenreich H; Bähr M
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1514-22. PubMed ID: 15111610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.